Funders — corporate, governmental, and philanthropic — have different priorities, yet they are now reaching into scientific publishing, wearing OA as a glove that fits. This post explores the problems this is creating and might create if allowed to perpetuate.
In this first part of a three-part series, the intrusion of governments into scientific publishing is contemplated — its causes, current state, and possible effects.
One of the layers of impropriety regarding PubMed Central’s handling of eLife is its mismanagement of conflicts of interest.
More information emerges about PubMed Central, its processes, its relationship with eLife, and its role as a technology provider. Overall, it looks like certain OA friends get special treatment, and the processes you think occur are often short-circuited and may not even be tracked.